Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
03/10/2004 | CN1141085C Water soluble clomiphene preparation and its preparation method |
03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
03/09/2004 | US6703410 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
03/04/2004 | WO2004018483A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
03/04/2004 | WO2004018480A1 6h-thieno`2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh) |
03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
03/04/2004 | WO2004018434A1 Pyrimidine compounds |
03/04/2004 | WO2004018431A2 Novel phenanthridines |
03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
03/04/2004 | WO2004017983A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
03/04/2004 | WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces |
03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
03/04/2004 | WO2002015938A8 Testosterone ester formulation for human use |
03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
03/04/2004 | US20040044086 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
03/04/2004 | US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists |
03/04/2004 | US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
03/04/2004 | US20040044011 2-Aminoalkyl-thieno[2,3-d]pyrimidines |
03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
03/04/2004 | US20040043976 16Alpha-methyl or ethyl substituted estrogens |
03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
03/04/2004 | US20040043080 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
03/04/2004 | US20040043032 Vaccine |
03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
03/04/2004 | CA2495597A1 Novel phenanthridines |
03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
03/03/2004 | EP1393737A1 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
03/03/2004 | EP1392700A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
03/03/2004 | EP1392699A1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
03/03/2004 | EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives |
03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
03/03/2004 | EP1392666A1 Biologically active methylene blue derivatives |
03/03/2004 | EP1392655A2 Potassium channel openers |
03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
03/03/2004 | EP1392399A1 Use and compositions of antiprogestins for treatment of prostate diseases |
03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
03/03/2004 | EP1392326A1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
03/03/2004 | EP1392247A2 Process for preparing granular compositions |
03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
03/03/2004 | EP1169064B1 Method of detecting endometriosis |
03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
03/03/2004 | CN1479747A Methylene steroids as novel androgens |
03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
03/03/2004 | CN1479736A Benzofuran and benzothiophene derivatives |
03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
03/03/2004 | CN1479619A Use of pyrazolo [4,3-d] pyrimidines |
03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
03/03/2004 | CN1478476A Medicine for treating venereal wart and its preparation method |
03/03/2004 | CN1140526C 8-azabicyclo[3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 doppamine and 5HT1A and 5HT2 serotonin receptors |
03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
03/03/2004 | CN1140289C Gynopathy treating Chinese patent drag with forution of diminishing inflammation and eliminating spot and its prepn. method |
03/03/2004 | CN1140282C External use medicine for treating sexual disorder for male |
03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
03/02/2004 | US6699833 Pharmaceutical formulations for sustained drug delivery |
03/02/2004 | US6699832 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia |
03/02/2004 | US6699498 Transdermal therapeutic systems having improved stability and their production |
03/02/2004 | US6699494 Side effect reduction |
02/28/2004 | CA2436708A1 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
02/26/2004 | WO2004016608A1 Novel quinuclidine derivatives and their use |
02/26/2004 | WO2004016601A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
02/26/2004 | WO2004016593A1 Diaryl compounds as monoamine reuptake inhibitors |
02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
02/26/2004 | WO2004016272A1 Use of reboxetine for the treatment of hot flashes |